News - Takeda Pharmaceuticals, Metabolics

Filter

Popular Filters

Takeda acquires vaccine maker LigoCyte; signs multi-drug discovery deal with Advinus

05-10-2012

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) says it is to acquire privately-held US vaccine…

Advinus TherapeuticsInflammatory diseasesLicensingLigoCyteMergers & AcquisitionsMetabolicsNeurologicalPharmaceuticalTakeda PharmaceuticalsVaccines

Another FDA hurdle for Orexigen obesity drug candidate

07-02-2012

It might seem to some that the US Food and Drug Administration has no intentions of approving any new…

ContraveMetabolicsNorth AmericaOrexigen TherapeuticsPharmaceuticalRegulationResearchTakeda Pharmaceuticals

Orexigen and FDA find way forward for obesity drug Contrave

21-09-2011

Shares of US drug developer Orexigen Therapeutics (Nasdaq: OREX) 86% to $2.74 in extended trading yesterday,…

ContraveMetabolicsNorth AmericaOrexigen TherapeuticsPharmaceuticalRegulationResearchTakeda Pharmaceuticals

Amylin and Takeda drop combo obesity drug development

08-08-2011

Amylin Pharmaceuticals (Nasdaq: AMLN) and Japan’s Takeda Pharmaceutical (TSE: 4502) are discontinuing…

AmylinMetabolicsmetreleptinPharmaceuticalpramlintideResearchTakeda Pharmaceuticals

Back to top